
收稿日期: 2024-10-12
录用日期: 2025-03-05
网络出版日期: 2025-07-14
基金资助
国家自然科学基金面上项目(82070207);上海交通大学医学院“双百人”项目(20221807)
Clinicopathological features of 12 cases of epithelioid hemangioendothelioma
Received date: 2024-10-12
Accepted date: 2025-03-05
Online published: 2025-07-14
Supported by
National Natural Science Foundation of China(82070207);“Two-hundred Talents” Program of Shanghai Jiao Tong University School of Medicine(20221807)
目的·探索上皮样血管内皮瘤(epithelioid hemangioendothelioma,EHE)患者的临床、病理及分子遗传学特征及其预后。方法·收集2016年9月至2023年12月上海交通大学医学院附属仁济医院确诊的12例EHE患者的临床及随访资料,组织样本分别行苏木精-伊红(hematoxylin-eosin,H-E)染色、免疫组织化学(immunohistochemistry,IHC)染色和荧光原位杂交(fluorescence in situ hybridization,FISH)检测。结果·12例患者中男性患者3名、女性9名,平均年龄(47.17±11.15)岁;肿瘤分布为肝脏6例、肺4例、纵隔1例、右锁骨上1例;无症状患者9例,其余3例患者因胸闷、乏力等轻微不适症状就医。CT检查显示发生在肝脏和肺部的EHE患者均为多发结节,其中2例同时累及肝脏和肺;发生在锁骨上及纵隔的EHE患者为单发结节。H-E染色显示:肿瘤组织由上皮样细胞、树突状细胞和中间细胞构成,排列呈腺泡状、条索状或簇状;上皮样细胞具有圆形泡状核及嗜酸性胞质,部分细胞呈印戒样外观伴胞质空泡;间质含黏液样基质。IHC染色显示:肿瘤组织的间叶源性血管内皮标志物波形蛋白、CD31、ETS转录因子ERG、凝血第Ⅷ因子相关抗原均为阳性,而上皮源性标志物阳性率低且仅呈弱阳性,Ki-67指数也较低。FISH检测显示:10例患者存在钙调素结合转录激活因子1(calmodulin-binding transcription activator 1,CAMTA1)基因断裂,另2例患者存在转录因子E3(transcription factor E3,TFE3)基因断裂。12例患者中11例获得随访结果,随访时间2~38个月,平均21.7个月,其中3例无瘤生存,6例带瘤生存,1例术后4个月死亡,1例术后24个月因心脏病死亡。结论·EHE临床特征不典型、易复发、预后差异较大;组织病理学结合IHC及分子检测有助于明确诊断。
隋成亮 , 沈艳莹 , 刘泽兵 . 上皮样血管内皮瘤12例临床病理学分析[J]. 上海交通大学学报(医学版), 2025 , 45(7) : 892 -899 . DOI: 10.3969/j.issn.1674-8115.2025.07.011
Objective ·To investigate the clinical, pathological, and molecular genetic features and prognosis of epithelioid hemangioendothelioma (EHE) patients. Methods ·Clinical and follow-up data of 12 EHE patients diagnosed at Renji Hospital, Shanghai Jiao Tong University School of Medicine from September 2016 to December 2023 were collected. Tissue samples were analyzed using hematoxylin-eosin (H-E) staining, immunohistochemistry (IHC), and fluorescence in situ hybridization (FISH). Results ·Among the 12 patients, there were 3 males and 9 females, with a mean age of (47.17±11.15) years. Tumors were located in the liver (6 cases), lung (4 cases), mediastinum (1 case), and supraclavicular region (1 case). Nine patients were asymptomatic, while 3 presented with mild symptoms such as chest tightness and fatigue. CT imaging revealed that EHE patients with involvement of livers and lungs exhibited multiple nodules, and 2 cases had tumors in both organs. Patients with tumors in the supraclavicular region and mediastinum presented with solitary nodules. H-E staining demonstrated that tumor tissues were composed of epithelioid, dendritic, and intermediate cells, arranged in acinar, cord-like, or clustered patterns. Epithelioid cells had round vesicular nuclei and eosinophilic cytoplasm, with some showing a signet-ring appearance and cytoplasmic vacuoles. The stroma contained a mucoid matrix. IHC staining revealed that mesenchymal endothelial markers, including vimentin, CD31, ETS transcription factor ERG, and factor Ⅷ-related antigen, were positive in the tumor tissues, while epithelial markers showed low positivity with weak staining. The Ki-67 indexes were also low. FISH analysis showed that 10 patients had a calmodulin-binding transcription activator 1 (CAMTA1) gene break, while 2 patients had a transcription factor E3 (TFE3) gene break. Of the 12 patients, 11 were followed up for 2 to 38 months, with a mean follow-up time of 21.7 months. Three patients achieved tumor-free survival, 6 were alive with tumors, 1 died 4 months after surgery, and 1 died of heart disease 24 months after surgery. Conclusion ·EHE has atypical clinical features, a tendency to recur, a and variable prognosis. Accurate diagnosis requires a combination of histopathology, IHC, and a molecular testing.
| [1] | 李卓, 杜强, 马沛卿, 等. 肝上皮样血管内皮瘤14例临床病理学特点分析[J]. 中华病理学杂志, 2021, 50(5): 511-513. |
| LI Z, DU Q, MA P Q, et al. Clinicopathological characteristics of hepatic epithelioid hemangioendothelioma[J]. Chinese Journal of Pathology, 2021, 50(5): 511-513. | |
| [2] | STUDER L L, SELBY D M. Hepatic epithelioid hemangioendothelioma[J]. Arch Pathol Lab Med, 2018, 142(2): 263-267. |
| [3] | 弋春燕, 马捷, 曾显荣, 等. 前纵隔上皮样血管内皮瘤CT表现与病理相关征象分析[J]. 中国CT和MRI杂志, 2023, 21(1): 89-91. |
| YI C Y, MA J, ZENG X R, et al. Analysis of pathological and CT features of anterior mediastinum epithelioid hemangioendothelioma[J]. Chinese Journal of CT and MRI, 2023, 21(1): 89-91. | |
| [4] | TSUCHIHASHI K, BABA E S. Epithelioid hemangioendothelioma-its history, clinical features, molecular biology and current therapy[J]. Jpn J Clin Oncol, 2024, 54(7): 739-747. |
| [5] | 魏淑飞, 韩永良, 张卢舜, 等. 肝脏上皮样血管内皮瘤44例临床病理观察[J]. 临床与实验病理学杂志, 2022, 38(12): 1492-1496. |
| WEI S F, HAN Y L, ZHANG L S, et al. Clinicopathological observation of hepatic epithelioid hemangioendothelioma: a study of 44 cases[J]. Chinese Journal of Clinical and Experimental Pathology, 2022, 38(12): 1492-1496 | |
| [6] | LAU K, MASSAD M, POLLAK C, et al. Clinical patterns and outcome in epithelioid hemangioendothelioma with or without pulmonary involvement: insights from an internet registry in the study of a rare cancer[J]. Chest, 2011, 140(5): 1312-1318. |
| [7] | LYTLE M, BALI S D, GALILI Y, et al. Epithelioid hemangioendothelioma: a rare case of an aggressive vascular malignancy[J]. Am J Case Rep, 2019, 20: 864-867. |
| [8] | 陈少芳, 庄丹萍, 金红涛, 等. 肝脏、双肺同时发生的上皮样血管内皮瘤影像表现一例并文献复习[J]. 磁共振成像, 2024, 15(3): 187-189. |
| CHEN S F, ZHUANG D P, JIN H T, et al. Epithelioid hemangioendothelioma involving both liver and lung: one case report[J]. Chinese Journal of Magnetic Resonance Imaging, 2024, 15(3): 187-189. | |
| [9] | 方燕红, 刘向一, 倪云燕, 等. 肝脏上皮样血管内皮瘤的影像学表现[J]. 中国卫生标准管理, 2023, 14(24): 82-86. |
| FANG Y H, LIU X Y, NI Y Y, et al. Imaging manifestations of hepatic epithelioid hemangioendothelioma[J]. China Health Standard Management, 2023, 14(24): 82-86. | |
| [10] | 叶枫, 蒋力明, 宋颖, 等. 肝脏上皮样血管内皮瘤的影像学特征[J]. 中华消化外科杂志, 2017, 16(2): 201-206. |
| YE F, JIANG L M, SONG Y, et al. Imaging features of hepatic epithelioid hemangioendothelioma[J]. Chinese Journal of Digestive Surgery, 2017, 16(2): 201-206. | |
| [11] | 董淑慧, 杨勇, 刘爱东, 等. 骨原发性上皮样血管内皮瘤2例临床病理学分析并文献复习[J]. 诊断病理学杂志, 2024, 31(8): 711-714. |
| DONG S H, YANG Y, LIU A D, et al. Clinicopathological features of primary epithelioid hemangioendothelioma originated in bone: report of two cases and literature review[J]. Chinese Journal of Diagnostic Pathology, 2024, 31(8): 711-714. | |
| [12] | 王帅, 吕明, 梅丽. 上皮样血管内皮瘤6例临床病理分析[J]. 中国实验诊断学, 2024, 28(9): 1075-1078. |
| WANG S, Lü M, MEI L. Clinicopathological analysis of 6 cases of epithelioid hemangioendothelioma[J]. Chinese Journal of Laboratory Diagnosis, 2024, 28(9): 1075-1078. | |
| [13] | 马晓燕, 方建强, 石艳宏, 等. 肝脏上皮样血管内皮瘤穿刺标本的病理特征[J]. 诊断病理学杂志, 2023, 30(8): 799-801. |
| MA X Y, FANG J Q, SHI Y H, et al. Pathological features of hepatic epithelioid hemangioendothelioma of needle biopsy specimen[J]. Chinese Journal of Diagnostic Pathology, 2023, 30(8): 799-801. | |
| [14] | NOH O K, KIM S S, YANG M J, et al. Treatment and prognosis of hepatic epithelioid hemangioendothelioma based on SEER data analysis from 1973 to 2014[J]. Hepatobiliary Pancreat Dis Int, 2020, 19(1): 29-35. |
| [15] | 倪海春, 谢永辉, 章宏峰. 肺上皮样血管内皮瘤4例临床病理观察[J]. 临床肿瘤学杂志, 2023, 28(9): 836-841. |
| NI H C, XIE Y H, ZHANG H F. Pulmonary epithelioid hemangioendothelioma: a clinicopathological analysis of four cases[J]. Chinese Clinical Oncology, 2023, 28(9): 836-841. | |
| [16] | 王湛博, 安晓静, 邓晋芳, 等. 肝脏恶性血管源性肿瘤中ERG、Fli-1、CD34、CD31、FⅧRAg的表达特征[J]. 中华病理学杂志, 2017, 46(11): 760-763. |
| WANG Z B, AN X J, DENG J F, et al. Characteristics of ERG, Fli-1, CD34, CD31 and FⅧRAg expression in hepatic malignant vascular tumors[J]. Chinese Journal of Pathology, 2017, 46(11): 760-763. | |
| [17] | FLUCKE U, VOGELS R J C, DE SAINT AUBAIN SOMERHAUSEN N, et al. Epithelioid Hemangioendothelioma: clinicopathologic, immunohistochemical, and molecular genetic analysis of 39 cases[J]. Diagn Pathol, 2014, 9: 131. |
| [18] | ROSENBAUM E, JADEJA B, XU B, et al. Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets[J]. Mod Pathol, 2020, 33(4): 591-602. |
| [19] | DOYLE L A, FLETCHER C D M, HORNICK J L. Nuclear expression of CAMTA1 distinguishes epithelioid hemangioendothelioma from histologic mimics[J]. Am J Surg Pathol, 2016, 40(1): 94-102. |
| [20] | LOTFALLA M M, FOLPE A L, FRITCHIE K J, et al. Hepatic YAP1-TFE3 rearranged epithelioid hemangioendothelioma[J]. Case Rep Gastrointest Med, 2019, 2019: 7530845. |
| [21] | WU X, LI B L, ZHENG C J, et al. Clinical characteristics of epithelioid hemangioendothelioma: a single-center retrospective study[J]. Eur J Med Res, 2019, 24(1): 16. |
| [22] | ATYAH M M, SUN Y L, YANG Z Y. The challenges of hepatic epithelioid hemangioendothelioma: the diagnosis and current treatments of a problematic tumor[J]. Orphanet J Rare Dis, 2024, 19(1): 449. |
| [23] | TORRENCE D, ANTONESCU C R. The genetics of vascular tumours: an update[J]. Histopathology, 2022, 80(1): 19-32. |
/
| 〈 |
|
〉 |